METHODS: The participants were 26 UVFP patients who underwent laryngeal framework surgery (TP1 and/or AA). U-HRCT was used to measure the vocal fold volume (VFV) and level difference (LD). The need to combine AA with TP1 to obtain satisfactory surgical outcomes was evaluated by U-HRCT and various voice function tests.
RESULTS: VFV was smaller in paralyzed folds than in unaffected folds. LD correlated strongly with voice parameters and showed high intra-rater and inter-rater reliability. The surgical outcome of the laryngeal framework surgery performed was judged to be excellent for improving voice function. Comparison of LD between the TP1 group and TP1 + AA group indicated that LD is an excellent parameter to determine the need to combine AA with TP1.
CONCLUSIONS: These findings underscore the value of preoperative U-HRCT, especially LD, in surgical decision-making and afford insights for optimal phonosurgery and individualized intervention. Patients with LD >1.0 mm may benefit from thyroplasty with AA.
METHODS: Level 3 (case-control study) Laryngoscope, 2024.
方法:参与者是26例接受喉框架手术(TP1和/或AA)的UVFP患者。使用U-HRCT测量声带体积(VFV)和水平差(LD)。通过U-HRCT和各种语音功能测试评估了将AA与TP1结合以获得满意的手术结果的必要性。
结果:瘫痪褶皱的VFV小于未受影响的褶皱。LD与语音参数密切相关,并显示出较高的评分者内部和评分者之间的可靠性。喉框架手术的手术结果被认为是改善语音功能的极好。TP1组和TP1+AA组之间LD的比较表明,LD是确定AA与TP1组合需要的极好参数。
结论:这些发现强调了术前U-HRCT的价值,尤其是LD,在手术决策中,为最佳语音手术和个性化干预提供见解。LD>1.0mm的患者可从AA甲状腺成形术中获益。
方法:三级(病例对照研究)喉镜,2024.